Amarin Corp Plc (AMRN)

[Whalatane]

Atom are U suggesting that the FDA will not include diabetics with 1 additional risk factor because the RRR is ONLY 12% ??

Ezetimibe is approved for what I recall is even less the that .

Its a risk / benefit analysis based on data . What the risk for including these primary prevention diabetic ....?


The benefit is 12% RRR...whats the risk ?

ASCVD is largely secondary prevention so they will be included anyway .

Thx for the debate ..just trying to understand your view .
Kiwi